| Patents for C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979) |
|---|
| 05/10/2011 | US7939533 Dual NK1/NK3 receptor antagonists |
| 05/10/2011 | US7939532 Heterocyclyl pyridyl sulfonamide derivatives, their manufacture and use as pharmaceutical agents |
| 05/10/2011 | US7939528 Heterocycle compounds |
| 05/10/2011 | US7939523 Imidazolidinone and imidazolidinethione derivatives |
| 05/10/2011 | US7939520 Aminoazacyclyl-3-sulfonylindazoles as 5-hydroxytryptamine-6 ligands |
| 05/10/2011 | US7939185 Fused polycyclic compounds and organic light-emitting device using the same |
| 05/10/2011 | CA2671369C Crystal of benzimidazole compound |
| 05/10/2011 | CA2614746C Heteroaryl benzamide derivatives for use as glk activators in the treatment of diabetes |
| 05/10/2011 | CA2494208C N-aryl piperidine substituted biphenylcarboxamides as inhibitors of apolipoprotein b secretion |
| 05/10/2011 | CA2473572C Quinazoline compounds |
| 05/10/2011 | CA2467471C Derivatives of andrimid and moiramide b having antibacterial properties |
| 05/10/2011 | CA2436935C Serine protease inhibitors |
| 05/10/2011 | CA2433158C Pyridone derivatives having a binding activity to the cannabinoid type 2 receptor |
| 05/10/2011 | CA2419633C Substituted imidazoles as tafia inhibitors |
| 05/05/2011 | WO2011053706A1 4-substituted-2-phenoxy-phenylamine delta opioid receptor modulators |
| 05/05/2011 | WO2011053705A1 Pyrimidine compounds as delta opioid receptor modulators |
| 05/05/2011 | WO2011053701A1 Phenoxy-substituted pyrimidines as opioid receptor modulators |
| 05/05/2011 | WO2011053696A1 Pyrazines as delta opioid receptor modulators |
| 05/05/2011 | WO2011053511A1 Heteroaryl substituted arylindenopyrimidines and their use as highly selective adenosine a2a receptor antagonists |
| 05/05/2011 | WO2011053510A1 Heterocyclyl substituted arylindenopy-rimidines and their use as highly selective adenosine a2a receptor antagonists |
| 05/05/2011 | WO2011053507A1 2-amino-9-[4-(4-methoxy-phenoxy) - piperid in -1-yl] -4-phenyl-indeno [1,2-d] pyrimidin -5 -one and its use as a highly selective adenosine a2a receptor antagonist |
| 05/05/2011 | WO2011053090A2 Novel 2, 4-pyrimidine derivatives and use thereof |
| 05/05/2011 | WO2011052628A1 Angiogenesis promoter |
| 05/05/2011 | WO2011052554A1 Novel 5-fluorouracil derivative |
| 05/05/2011 | WO2011051958A1 Fungicidal pyrazolones |
| 05/05/2011 | WO2011051858A1 Imidazole derivatives as casein kinase inhibitors |
| 05/05/2011 | WO2011051814A1 Novel crystalline forms of (3r,6r) -3- (2, 3 -dihydro- 1h- inden- 2 -yl) - 1 - [ (1r) - 1 - (2, 6 - dimethyl - 3 - pyridinyl) - 2 - (4 -morpholinyl) -2-oxoethyl] -6- [(1s) - 1 -methylpropyl] -2,5- piperazinedione |
| 05/05/2011 | WO2011051540A1 Androgen receptor modulating compounds |
| 05/05/2011 | WO2011051490A2 Heterocyclic derivatives |
| 05/05/2011 | WO2011051324A1 Radiolabelled pde10 ligands |
| 05/05/2011 | WO2011051201A1 Positive allosteric modulators (pam) |
| 05/05/2011 | WO2011050962A1 Acid addition salts of lenalidomide |
| 05/05/2011 | WO2011050590A1 Polymorph of 3-(substituteddihydroisoindolinone-2-yl)-2,6-dioxopiperidine, and pharmaceutical compositions thereof |
| 05/05/2011 | WO2011006803A9 3-0x0-2, 3, -dihydro-1h-isoindole-4-carboxamides with selective parp-1 inhibition |
| 05/05/2011 | WO2011006794A9 3-oxo-2, 3-dihydro-1h-isoindole-4-carboxamides as parp inhibitors |
| 05/05/2011 | WO2010151737A3 Heterocyclic compounds and their uses as inhibitors of pi3 k activity |
| 05/05/2011 | US20110105758 Process for the preparation of enantiomerically enriched cyclic beta-aryl or heteroarylcarbocyclic acids |
| 05/05/2011 | US20110105753 Process for the preparation of pyrazinone thrombin inhibitor and its intermediates |
| 05/05/2011 | US20110105749 Triazole compounds that modulate hsp90 activity |
| 05/05/2011 | US20110105747 Quinoline derivative and quinazoline derivative inhibiting self-phosphorylation of hepatocytus proliferator receptor, and medicinal composition containing the same |
| 05/05/2011 | US20110105567 Pyrrole Compounds Having Sphingosine-1-Phosphate Receptor Agonist Or Antagonist Biological Activity |
| 05/05/2011 | US20110105566 Fungicide hydroximoyl-tetrazole derivatives |
| 05/05/2011 | US20110105564 Thienylpyridylcarboxamides |
| 05/05/2011 | US20110105562 Alkynyl derivatives useful as dpp-1 inhibitors |
| 05/05/2011 | US20110105557 Farnesyl protein transferase inhibitor combinations with antiestrogen agents |
| 05/05/2011 | US20110105556 Tris-quarternary ammonium salts and methods for modulating neuronal nicotinic acetylcholine receptors |
| 05/05/2011 | US20110105543 Novel triaryl derivatives useful as modulators of nicotinic acetylcholine receptors |
| 05/05/2011 | US20110105540 2-AMINO-9-[4-(4-METHOXY-PHENOXY)-PIPERIDIN-1-YL]-4-PHENYL-INDENO[1,2-D]PYRIMIDIN-5-ONE AND ITS USE AS A HIGHLY SELECTIVE ADENOSINE A2a RECEPTOR ANTAGONIST |
| 05/05/2011 | US20110105530 Organic compounds |
| 05/05/2011 | US20110105527 Pyrazines as delta opioid receptor modulators |
| 05/05/2011 | US20110105513 AMINO-QUINOXALINE AND AMINO-QUINOLINE COMPOUNDS FOR USE AS ADENOSINE A2a RECEPTOR ANTAGONISTS |
| 05/05/2011 | US20110105512 Bridged bicyclic heteroaryl substituted triazoles useful as axl inhibitors |
| 05/05/2011 | US20110105511 Polycyclic heteroaryl substituted triazoles useful as axl inhibitors |
| 05/05/2011 | US20110105509 Indole based receptor crth2 antagonists |
| 05/05/2011 | US20110105508 Quinoxaline and quinoline derivatives as kinase inhibitors |
| 05/05/2011 | US20110105503 Aralkyl piperidine derivatives and their uses as antalgic or ataractic agent |
| 05/05/2011 | US20110105493 HETEROCYCLYL SUBSTITUTED ARYLINDENOPYRIMIDINES AND THEIR USE AS HIGHLY SELECTIVE ADENOSINE A2a RECEPTOR ANTAGONISTS |
| 05/05/2011 | US20110105486 Thiazole derivatives |
| 05/05/2011 | US20110105485 Alpha-(N-Sulfonamido)Acetamide Derivatives as Beta-Amyloid Inhibitors |
| 05/05/2011 | US20110105477 Compositions and methods relating to hiv protease inhibition |
| 05/05/2011 | US20110105474 Heterocyclic derivatives as hdac inhibitors |
| 05/05/2011 | US20110105472 Diaminopyrimidines as crop protection agents |
| 05/05/2011 | US20110105460 Triazole derivative or salt thereof |
| 05/05/2011 | US20110105459 Azetidines and cyclobutanes as histamine h3 receptor antagonists |
| 05/05/2011 | US20110105456 3-phenyl-pyrazole derivatives as modulators of the 5-ht2a serotonin receptor useful for the treatment of disorders related thereto |
| 05/05/2011 | US20110105455 Phenoxy-substituted pyrimidines as opioid receptor modulators |
| 05/05/2011 | US20110105454 Substituted oxindole-derivatives and the use thereof for the treatment of vasopressin-dependent illnesses |
| 05/05/2011 | US20110105447 Novel modulators of calcium release-activated calcium channel |
| 05/05/2011 | US20110105440 HEXAHYDROCYCLOPENTYL[f]INDAZOLE SULFONAMIDES AND DERIVATIVES THEREOF AS SELECTIVE GLUCOCORTICOID RECEPTOR MODULATORS |
| 05/05/2011 | US20110105436 Heteroaryl compounds, compositions, and methods of use in cancer treatment |
| 05/05/2011 | US20110105432 Aminocarboxylic acid derivative and medicinal use thereof |
| 05/05/2011 | US20110105362 Cyanine compounds and their application as quenching compounds |
| 05/05/2011 | US20110104315 Tetrahydroquinoline derivatives as cannabinoid receptor modulators |
| 05/05/2011 | US20110104207 Gyrase inhibitors and uses thereof |
| 05/05/2011 | US20110104115 Inhibitors of serine proteases, particularly hcv ns3-ns4a protease |
| 05/05/2011 | US20110104110 Substituted indole derivatives and methods of use thereof |
| 05/05/2011 | CA2779452A1 2-aminoindole compounds and methods for the treatment of malaria |
| 05/05/2011 | CA2779124A1 Heteroaryl substituted arylindenopyrimidines and their use as highly selective adenosine a2a receptor antagonists |
| 05/05/2011 | CA2779120A1 Heterocyclyl substituted arylindenopy-rimidines and their use as highly selective adenosine a2a receptor antagonists |
| 05/05/2011 | CA2779108A1 4-substituted-2-phenoxy-phenylamine delta opioid receptor modulators |
| 05/05/2011 | CA2779107A1 Pyrimidine compounds as delta opioid receptor modulators |
| 05/05/2011 | CA2779091A1 2-amino-9-[4-(4-methoxy-phenoxy)-piperidin-1-yl]-4-phenyl-indeno[1,2-d]pyrimidin-5-one and its use as a highly selective adenosine a2a receptor antagonist |
| 05/05/2011 | CA2779083A1 Pyrazines as delta opioid receptor modulators |
| 05/05/2011 | CA2778979A1 Phenoxy-substituted pyrimidines as opioid receptor modulators |
| 05/05/2011 | CA2778219A1 Positive allosteric modulators (pam) |
| 05/05/2011 | CA2777896A1 Androgen receptor modulating compounds |
| 05/05/2011 | CA2777632A1 Imidazole derivatives as casein kinase inhibitors |
| 05/05/2011 | CA2776240A1 Radiolabelled pde10 ligands |
| 05/04/2011 | EP2316831A1 2,4,6-trisubstituted pyrimidines as phosphotidylinositol (PI) 3-kinase inhibitors and their use in the treatment of cancer |
| 05/04/2011 | EP2316829A1 Heterocyclic derivatives as modulators of ion channels |
| 05/04/2011 | EP2316459A1 Methods of treating or preventing autoimmune diseases with 2,4-pyrimidinediamine compounds |
| 05/04/2011 | EP2316455A1 Pharmaceutical compositions for treating cancer |
| 05/04/2011 | EP2315763A1 Benzimidazoles and related analogs as sirtuin modulators |
| 05/04/2011 | EP2315762A2 Fluoro-substituted 3,4-diaryl-4,5-dihydro-1h-pyrazole-1-carboxamidine derivatives having cb1-antagonistic activity |
| 05/04/2011 | EP2315761A1 Pharmaceutical compounds |
| 05/04/2011 | EP2315760A1 Piperazine compounds with herbicidal effect |
| 05/04/2011 | EP2315749A2 New therapeutic agents |
| 05/04/2011 | EP2315591A1 Novel pyrrole inhibitors of s-nitrosoglutathione reductase as therapeutic agents |
| 05/04/2011 | EP2315590A1 Pyrrole inhibitors of s-nitrosoglutathione reductase |
| 05/04/2011 | EP2315588A1 6-1h-imidazo-quinazoline and quinolines derivatives, new mao inhibitors and imidazoline receptor ligands |